Challenges and opportunities in evaluating diagnostic tests

Journal of Clinical Epidemiology

Volumn 55, Issue 12, 2002, Pages 1178-1182

  Ransohoff, David F ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Decision making; Diagnosis; Diagnostic tests; Sensitivity; Specificity

Indexed keywords

CLINICAL RESEARCH; DECISION MAKING; DIAGNOSTIC TEST; HEALTH CARE POLICY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW;

EID: 0036961853     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00524-3     Document Type: Article

References (21)

1. Feinstein A.R. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther. 17:1975;104-116.
2. Ransohoff D.F., Feinstein A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 299:1978;926-930.
3. Feinstein A.R. Misguided efforts and future challenges for research on "diagnostic tests." J Epidemiol Commun Health. 56:2002;330-332.
4. Nierenberg A.A., Feinstein A.R. How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. JAMA. 259:1988;1699-1702.
5. Lachs M.S., Nachamkin I., Edelstein P.H., Goldman J., Feinstein A.R., Schwartz J.S. Spectrum bias in the evaluation of diagnostic tests. lessons from the rapid dipstick test for urinary tract infection Ann Intern Med. 117:1992;135-140.
6. Reid M.C., Lachs M.S., Feinstein A.R. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA. 274:1995;645-651.
7. Jaeschke R., Guyatt G.H., Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 271:1994;703-707.
8. Irwig L., Tosteson A.N., Gatsonis C., Lau J., Colditz G., Chalmers T.C.et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 120:1994;667-676. [see comments].
9. Perou CM, Brown PO, Botstein D. Tumor classification using gene expression patterns from DNA microarrays. Mol Med Today 2000:67-76.
10. Harris R.P., Helfand M., Woolf S.H., Lohr K.N., Mulrow C.D., Teutsch S.M.et al. Current methods of the US Preventive Services Task Force. a review of the process Am J Prev Med. 20(3 Suppl):2001;21-35.
11. Sox H.C. Jr. Preventive health services in adults. N Engl J Med. 330:1994;1589-1595.
12. Redelmeier D.A., Tversky A. Discrepancy between medical decisions for individual patients and for groups. N Engl J Med. 322:1990;1162-1164.
13. Redelmeier D.A., Rozin P., Kahneman D. Understanding patients' decisions. cognitive and emotional perspectives JAMA. 270:1993;72-76.
14. Schwartz L.M., Woloshin S., Black W.C., Welch H.G. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 127:1997;966-972. [see comments].
15. Woloshin S., Schwartz L.M., Byram S.J., Sox H.C., Fischhoff B. How realistic are women about the benefit and downstream consequences of screening mammography? J Gen Intern Med. 13:1998;100. [abstract].
16. Sackett D.L., Holland W.W. Controversy in the detection of disease. Lancet. ii:1975;357-359.
17. Ransohoff D.F., Collins M.M., Fowler F.J. Jr. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 113:2002;663-667.
18. Kolata G. Questions grow over usefulness of some routine cancer tests. New York Times. Dec 30:2001;A1-18.
19. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer. 2:2002;210-219.
20. Bogardus S.T., Concato J., Feinstein A.R. Clinical epidemiological quality in molecular genetic research. the need for methodological standards JAMA. 281:1999;1919-1926.
21. Ransohoff D.F. Research opportunity at the interface of molecular biology and clinical epidemiology. Gastroenterology. 122:2002;1199.